GlassScriptPhysician profile
James Anthony Reed
NPI 1770548588
$2,773.92
in general payments reported to CMS, 2019-2025
23 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.32 · 2020: $101 · 2021: $135 · 2022: $253 · 2023: $262 · 2024: $330 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $765.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2025 | |
| Sumitomo Pharma America, INC. | $295.48 | 2024-2025 | Myfembree |
| Axonics, INC. | $128.64 | 2022 | |
| Astellas Pharma US INC | $127.02 | 2021-2023 | Veozah, Myrbetriq |
| Abbvie INC. | $104.17 | 2021-2022 | |
| Aspira Women'S Health INC | $100.63 | 2020 | |
| Coloplast Corp | $98.57 | 2023 | Altis |
| Hologic Sales and Service, LLC | $93.76 | 2022-2024 | Aptima |
| Optumhealth Care Solutions, LLC | $56.98 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pacira Pharmaceuticals Incorporated | $23.86 | 2023 | Exparel |
| Daiichi Sankyo INC. | $22.93 | 2022 | |
| Medtronic, INC. | $22.75 | 2023 | Interstim |
| Organon LLC | $22.69 | 2024 | |
| Lilly USA, LLC | $21.75 | 2022 | |
| Abbott Laboratories | $19.58 | 2023 | Proclaim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $19.32 | 2019 | |
| Exeltis, USA INC. | $18.67 | 2025 | Slynd |
| Lsi Solutions INC | $18.56 | 2025 | Fornisee |
| Shield Therapeutics INC | $18.25 | 2025 | |
| Boston Scientific Corporation | $16.12 | 2022 | |
| Mayne Pharma Commercial LLC | $16.07 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.04 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.